| Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology A Zimprich, S Biskup, P Leitner, P Lichtner, M Farrer, S Lincoln, ... Neuron 44 (4), 601-607, 2004 | 2475 | 2004 |
| Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin N Exner, B Treske, D Paquet, K Holmström, C Schiesling, S Gispert, ... Journal of Neuroscience 27 (45), 12413-12418, 2007 | 522 | 2007 |
| Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease A Sánchez‐Danés, Y Richaud‐Patin, I Carballo‐Carbajal, ... EMBO molecular medicine 4 (5), 380-395, 2012 | 419 | 2012 |
| Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys A Recasens, B Dehay, J Bové, I Carballo‐Carbajal, S Dovero, ... Annals of neurology 75 (3), 351-362, 2014 | 365 | 2014 |
| Leucine-rich repeat kinase 2 induces α-synuclein expression via the extracellular signal-regulated kinase pathway I Carballo-Carbajal, S Weber-Endress, G Rovelli, D Chan, B Wolozin, ... Cellular signalling 22 (5), 821-827, 2010 | 89 | 2010 |
| Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients R Fernández‐Santiago, I Carballo‐Carbajal, G Castellano, R Torrent, ... EMBO molecular medicine 7 (12), 1529-1546, 2015 | 68 | 2015 |
| Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis VM Carballo-Carbajal I, Laguna A, Romero-Giménez J, Cuadros T, Bové J ... Nature Communications, 973, 2019 | 25 | 2019 |
| Advances in Parkinson’s disease: 200 years later NLG Del Rey, A Quiroga-Varela, E Garbayo, I Carballo-Carbajal, ... Frontiers in neuroanatomy 12, 113, 2018 | 17 | 2018 |
| Selective α-synuclein knockdown in monoamine neurons by intranasal oligonucleotide delivery: potential therapy for parkinson’s disease D Alarcón-Arís, A Recasens, M Galofré, I Carballo-Carbajal, N Zacchi, ... Molecular Therapy 26 (2), 550-567, 2018 | 17 | 2018 |
| Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients A Recasens, I Carballo-Carbajal, A Parent, J Bové, E Gelpi, E Tolosa, ... Acta neuropathologica communications 6 (1), 8, 2018 | 10 | 2018 |
| The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity H Kim, C Calatayud, S Guha, I Fernández-Carasa, L Berkowitz, ... Molecular neurobiology 55 (9), 7533-7552, 2018 | 10 | 2018 |
| The E3 ubiquitin ligases TRIM17 and TRIM41 modulate α-synuclein expression by regulating ZSCAN21 I Lassot, S Mora, S Lesage, BA Zieba, E Coque, C Condroyer, ... Cell reports 25 (9), 2484-2496. e9, 2018 | 3 | 2018 |
| Intracellular crowding by age-dependent neuromelanin accumulation disrupts neuronal proteostasis and triggers Parkinson disease pathology M Vila, A Laguna, I Carballo-Carbajal Autophagy 15 (11), 2028-2030, 2019 | 1 | 2019 |
| The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against alpha-Synuclein-Induced Toxicity (vol 55, pg 7533, 2018) H Kim, C Calatayud, S Guha, I Fernandez-Carasa, L Berkowitz, ... MOLECULAR NEUROBIOLOGY 55 (9), 7553-7554, 2018 | | 2018 |
| Correction to: The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity H Kim, C Calatayud, S Guha, I Fernández-Carasa, L Berkowitz, ... Molecular neurobiology 55 (9), 7553-7554, 2018 | | 2018 |
| Selective suppression of α-Synuclein in monoaminergic neurons of mice by intranasal delivery of targeted small interfering RNA or antisense oligonucleotides: Potential therapy … A Recasens, M Galofré, I Carballo-Carbajal, A Ferrés-Coy, J Bové, ... | | 2013 |
| 1: Hatano T, Kubo S, Imai S, Maeda M, Ishikawa K, Mizuno Y, Hattori N. Leucine-rich repeat kinase 2 associates with lipid rafts. Hum Mol Genet. 2007 Mar 15; 16 (6): 678-90 … M Hulihan, RJ Uitti, DB Calne, AJ Stoessl, RF Pfeiffer, N Patenge, ... | | |
